RSS Feeds
Search

Press releases

Press releases

Displaying 1..10 of 680 - per page Next page
Order by
Simple online tool avoids counter-productive rejecting of meeting requests; doubtful requests are verified or withdrawn by requesting party. More
Two papers on Embil's novel triple-active topical products (Neo-Penotran® Forte and Neo-Penotran® Forte-L) have been accepted for presentation at the 4'th World Conference on Vaginitis, Costa Rica, 10-13 Jan 2004 More
Genesis 2010, Westminster, Thursday 9 December is on track to attract a larger than ever attendance to debate new medicines and healthcare products research. More
The International Journal of Clinical Pharmacology and Therapeutics April 2009 Issue has published the latest peer-reviewed science on TDS-Testosterone. More
Two probiotic strains “GM-080” and “GMNL-33,” developed and marketed by GenMont Biotech Inc., (TWOTC: 3164) have been approved by regulatory agencies in China, and can now be used as additive ingredients to food products in that market. More
Protein drug development company Mycenax Biotech Inc. (GreTai, Taiwan: 4726) announced today that its rheumatoid arthritis and psoriasis drug TuNEX®, a biosimilar version of etanercept, has successfully completed a Phase I trial in South Korea and Phase I More
FDA ISSUED ORDERS TO SOLVAY AND AUXILIUM TO ADD BLACK BOX LABELS TO THEIR PRODUCTS AS NOTIFICATION TO USERS OF DANGER OF UNINTENDED TRANSFERENCE OF TESTOSTERONE TO FAMILY MEMBERS. TRANSDERMAL TECHNOLOGIES TDS-TESTOSTERONE'S RAPIDLY ABSORBED FORMULA WILL More
BIOMEDICA FOSCAMA's leading drug Esafosfina® has been acknowledged as a safe and effective phosphorus source in total parenteral nutrition More
Unique Low T treatment expected to eliminate the problematic transference side effect More
Postec (TM) is more efficacious than isolated topical steroid in the non surgical treatment of phimosis in children and adults More
Displaying 1..10 of 680 - per page Next page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2014 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us